Human tissue plasminogen activator consisting essentially of t-PA residues to 160 to 527, pharmaceutical compositions and methods of treatment
US5234686A · kind A · utility
2Cited by
3References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 30, 1991 |
| Grant date | Aug 10, 1993 |
| Priority date | — |
| Expiry date | May 30, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A purified fibrinolytically active degraded species of tissue-type plasminogen activator comprising a fibrinolytically intact B chain of native t-PA linked to kringle 2 as the only functionally and structurally intact domain of native t-PA A chain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.